Review ArticleReview
G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future
Angel Mauricio Castro-Gamero, Julia Alejandra Pezuk, María Sol Brassesco and Luiz Gonzaga Tone
Cancer Biology & Medicine November 2018, 15 (4) 354-374; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0030
Angel Mauricio Castro-Gamero
1Human Genetics Laboratory, Institute of Natural Sciences, Federal University of Alfenas (UNIFAL-MG), Alfenas 37130-001, Brazil
Julia Alejandra Pezuk
2Biotechnology and Innovation in Health Program and Pharmacy Program, Anhanguera University São Paulo (UNIAN-SP), São Paulo 05145-200, Brazil
María Sol Brassesco
3Department of Biology, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040-901, Brazil
Luiz Gonzaga Tone
4Department of Pediatrics
5Department of Genetics, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto 14049-900, Brazil

References
- 1.↵
- Goodenberger ML,
- Jenkins RB.
- 2.↵
- Louis DN,
- Ohgaki H,
- Wiestler OD,
- Cavenee WK,
- Burger PC,
- Jouvet A, et al.
- 3.↵
- 4.↵
- Ohgaki H,
- Kleihues P.
- 5.↵
- Khosla D.
- 6.↵
- Malmström A,
- Grønberg BH,
- Marosi C,
- Stupp R,
- Frappaz D,
- Schultz H, et al.
- 7.↵
- Yung WKA,
- Albright RE,
- Olson J,
- Fredericks R,
- Fink K,
- Prados MD, et al.
- 8.↵
- Stupp R,
- Hegi ME,
- Mason WP,
- van den Bent MJ,
- Taphoorn MJB,
- Janzer RC, et al.
- 9.↵
- 10.↵
- 11.↵
- 12.↵
- Jaeckle KA,
- Eyre HJ,
- Townsend JJ,
- Schulman S,
- Knudson HM,
- Belanich M, et al.
- 13.↵
- Hegi ME,
- Diserens AC,
- Gorlia T,
- Hamou MF,
- de Tribolet N,
- Weller M, et al.
- 14.↵
- Newlands ES,
- Stevens MFG,
- Wedge SR,
- Wheelhouse RT,
- Brock C.
- 15.↵
- Gorlia T,
- van den Bent MJ,
- Hegi ME,
- Mirimanoff RO,
- Weller M,
- Cairncross JG, et al.
- 16.↵
- 17.↵
- 18.↵
- 19.↵
- Hartmann C,
- Hentschel B,
- Simon M,
- Westphal M,
- Schackert G,
- Tonn JC, et al.
- 20.↵The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008; 455: 1061–8.
- 21.
- Verhaak RGW,
- Hoadley KA,
- Purdom E,
- Wang V,
- Qi Y,
- Wilkerson MD, et al.
- 22.↵
- Brennan CW,
- Verhaak RGW,
- McKenna A,
- Campos B,
- Noushmehr H,
- Salama SR, et al.
- 23.↵
- 24.↵
- Manfredi JJ,
- Horwitz SB.
- 25.↵
- Wani MC,
- Taylor HL,
- Wall ME,
- Coggon P,
- McPhail AT.
- 26.↵
- 27.↵
- 28.↵
- Gidding CEM,
- Kellie SJ,
- Kamps WA,
- de Graaf SSN.
- 29.↵
- Fellner S,
- Bauer B,
- Miller DS,
- Schaffrik M,
- Fankhänel M,
- Spruß T, et al.
- 30.
- 31.↵
- Murray S,
- Briasoulis E,
- Linardou H,
- Bafaloukos D,
- Papadimitriou C.
- 32.↵
- 33.↵
- 34.↵
- Nehate C,
- Jain S,
- Saneja A,
- Khare V,
- Alam N,
- Dubey RD, et al.
- 35.↵
- Sang F,
- Feng P,
- Chen J,
- Ding YH,
- Duan XY,
- Zhai JD, et al.
- 36.↵
- Brunden KR,
- Gardner NM,
- James MJ,
- Yao YM,
- Trojanowski JQ,
- Lee VMY, et al.
- 37.↵
- 38.↵
- 39.↵
- di Mauro V,
- Catalucci D.
- 40.
- 41.
- Xu YY,
- Shen M,
- Sun Y,
- Gao P,
- Duan YR.
- 42.
- Gu GZ,
- Xia HM,
- Hu QY,
- Liu ZY,
- Jiang MY,
- Kang T, et al.
- 43.↵
- 44.↵
- Baumann BC,
- Kao GD,
- Mahmud A,
- Harada T,
- Swift J,
- Chapman C, et al.
- 45.↵
- Tsao CT,
- Kievit FM,
- Ravanpay A,
- Erickson AE,
- Jensen MC,
- Ellenbogen RG, er al.
- 46.
- Scott R,
- Karki M,
- Reisenauer MR,
- Rodrigues R,
- Dasari R,
- Smith WR, et al.
- 47.
- Fang KM,
- Liu JJ,
- Li CC,
- Cheng CC,
- Hsieh YT,
- Chai KM, et al.
- 48.
- Ghoochani A,
- Hatipoglu-Majernik G,
- Sehm T,
- Wach S,
- Buchfelder M,
- Taubert H, et al.
- 49.
- Shankaraiah N,
- Nekkanti S,
- Brahma UR,
- Praveen Kumar N,
- Deshpande N,
- Prasanna D, et al.
- 50.
- 51.
- Kato K,
- Ito H,
- Inaguma Y,
- Okamoto K,
- Saga S.
- 52.
- 53.
- Yoon JT,
- Palazzo AF,
- Xiao DH,
- Delohery TM,
- Warburton PE,
- Bruce JN, et al.
- 54.
- Yin D,
- Wakimoto N,
- Xing HT,
- Lu DN,
- Huynh T,
- Wang X, et al.
- 55.
- Bacher G,
- Nickel B,
- Emig P,
- Vanhoefer U,
- Seeber S,
- Shandra A, et al.
- 56.
- 57.
- 58.
- 59.
- Podolski-Renić A,
- Banković J,
- Dinić J,
- Ríos-Luci C,
- Fernandes MX,
- Ortega N, et al.
- 60.
- Fogh S,
- Machtay M,
- Werner-Wasik M,
- Curran WJ Jr.,
- Bonanni R,
- Axelrod R, et al.
- 61.
- 62.
- 63.
- 64.
- de Witt M,
- Gamble A,
- Hanson D,
- Markowitz D,
- Powell C,
- Al Dimassi S, et al.
- 65.
- Bai RY,
- Staedtke V,
- Wanjiku T,
- Rudek MA,
- Joshi A,
- Gallia GL, et al.
- 66.
- Stupp R,
- Tosoni A,
- Bromberg JEC,
- Hau P,
- Campone M,
- Gijtenbeek J, et al.
- 67.
- Fung S,
- Xu C,
- Hamel E,
- Wager-Miller JB,
- Woodruff G,
- Miller A, et al.
- 68.
- Beyer CF,
- Zhang N,
- Hernandez R,
- Vitale D,
- Lucas J,
- Nguyen T, et al.
- 69.
- 70.↵
- 71.↵
- 72.
- Lee BL,
- Liedke PE,
- Barrios CH,
- Simon SD,
- Finkelstein DM,
- Goss PE.
- 73.
- Pezuk JA,
- Brassesco MS,
- Morales AG,
- de Oliveira JC,
- de Oliveira HF,
- Scrideli CA, et al.
- 74.
- 75.↵
- 76.
- Patnaik A,
- Rosen LS,
- Tolaney SM,
- Tolcher AW,
- Goldman JW,
- Gandhi L, et al.
- 77.
- Raub TJ,
- Wishart GN,
- Kulanthaivel P,
- Staton BA,
- Ajamie RT,
- Sawada GA, et al.
- 78.
- 79.
- Jane EP,
- Premkumar DR,
- Cavaleri JM,
- Sutera PA,
- Rajasekar T,
- Pollack IF.
- 80.↵
- 81.↵
- Alonso M,
- Tamasdan C,
- Miller DC,
- Newcomb EW.
- 82.
- Cimini A,
- d’Angelo M,
- Benedetti E,
- D’Angelo B,
- Laurenti G,
- Antonosante A, et al.
- 83.
- Cobanoglu G,
- Turacli ID,
- Ozkan AC,
- Ekmekci A.
- 84.
- Zhong S,
- Wu B,
- Dong XC,
- Han YJ,
- Jiang SS,
- Zhang Y, et al.
- 85.
- 86.
- Zhang XP,
- Lv H,
- Zhou QY,
- Elkholi R,
- Chipuk JE,
- Reddy MVR, et al.
- 87.
- 88.
- Olmez I,
- Brenneman B,
- Xiao AZ,
- Serbulea V,
- Benamar M,
- Zhang Y, et al.
- 89.
- Michaud K,
- Solomon DA,
- Oermann E,
- Kim JS,
- Zhong WZ,
- Prados MD, et al.
- 90.
- Whittaker S,
- Madani D,
- Joshi S,
- Chung SA,
- Johns T,
- Day B, et al.
- 91.
- Erbayraktar Z,
- Alural B,
- Erbayraktar RS,
- Erkan EP.
- 92.
- Kolodziej M,
- Goetz C,
- di Fazio P,
- Montalbano R,
- Ocker M,
- Strik H, et al.
- 93.
- Cheng CK,
- Gustafson WC,
- Charron E,
- Houseman BT,
- Zunder E,
- Goga A, et al.
- 94.
- 95.
- Ali MA,
- Choy H,
- Habib AA,
- Saha D.
- 96.
- Greenall SA,
- Lim YC,
- Mitchell CB,
- Ensbey KS,
- Stringer BW,
- Wilding AL, et al.
- 97.
- Liu Z,
- Wang F,
- Zhou ZW,
- Xia HC,
- Wang XY,
- Yang YX, et al.
- 98.
- Kurokawa C,
- Geekiyanage H,
- Allen C,
- Iankov I,
- Schroeder M,
- Carlson B, et al.
- 99.
- Daniele S,
- Sestito S,
- Pietrobono D,
- Giacomelli C,
- Chiellini G,
- di Maio D, et al.
- 100.↵
- Hong X,
- O’Donnell JP,
- Salazar CR,
- van Brocklyn Jr.,
- Barnett KD,
- Pearl DK, et al.
- 101.
- 102.↵
- 103.
- 104.
- Li N,
- Maly DJ,
- Chanthery YH,
- Sirkis DW,
- Nakamura JL,
- Berger MS, et al.
- 105.↵
- 106.↵
- 107.↵
- 108.↵
- Morgan DO.
- 109.↵
- Pines J.
- 110.↵
- 111.↵
- Malumbres M.
- 112.
- Sherr CJ.
- 113.↵
- Hall M,
- Peters G.
- 114.↵
- Lam PYP,
- di Tomaso E,
- Ng HK,
- Pang JCS,
- Roussel MF,
- Hjelm NM.
- 115.↵
- 116.↵
- Meijer L.
- 117.↵
- de Azevedo WF Jr.,
- Canduri F,
- da Silveira NJF.
- 118.↵
- Brüsselbach S,
- Nettelbeck DM,
- Sedlacek HH,
- Müller R.
- 119.↵
- Bible KC,
- Kaufmann SH.
- 120.↵
- 121.↵
- Newcomb EW,
- Tamasdan C,
- Entzminger Y,
- Alonso J,
- Friedlander D,
- Crisan D, et al.
- 122.↵
- Hofmeister CC,
- Poi M,
- Bowers MA,
- Zhao WQ,
- Phelps MA,
- Benson DM, et al.
- 123.
- Jones JA,
- Rupert AS,
- Poi M,
- Phelps MA,
- Andritsos L,
- Baiocchi R, et al.
- 124.↵
- Blum W,
- Phelps MA,
- Klisovic RB,
- Rozewski DM,
- Ni WJ,
- Albanese KA, et al.
- 125.↵
- Parry D,
- Guzi T,
- Shanahan F,
- Davis N,
- Prabhavalkar D,
- Wiswell D, et al.
- 126.↵
- 127.
- 128.↵
- Fu W,
- Ma L,
- Chu B,
- Wang X,
- Bui MM,
- Gemmer J, et al.
- 129.↵
- 130.↵
- 131.↵
- 132.↵
- Dolloff NG,
- Allen JE,
- Dicker DT,
- Aqui N,
- Vogl D,
- Malysz J, et al.
- 133.↵
- 134.↵
- Baumann KH,
- Kim H,
- Rinke J,
- Plaum T,
- Wagner U,
- Reinartz S.
- 135.↵
- Dai Y,
- Rahmani M,
- Pei XY,
- Dent P,
- Grant S.
- 136.↵
- Dai Y,
- Rahmani M,
- Grant S.
- 137.↵
- Karp JE,
- Ross DD,
- Yang WD,
- Tidwell ML,
- Wei YT,
- Greer J, et al.
- 138.↵
- 139.↵
- Holkova B,
- Perkins EB,
- Ramakrishnan V,
- Tombes MB,
- Shrader E,
- Talreja N, et al.
- 140.↵
- Lu XP,
- Koch KS,
- Lew DJ,
- Dulic V,
- Pines J,
- Reed SI, et al.
- 141.↵
- Hartwell LH,
- Weinert TA.
- 142.↵
- D’Assoro AB,
- Lingle WL,
- Salisbury JL.
- 143.↵
- Knauf JA,
- Ouyang B,
- Knudsen ES,
- Fukasawa K,
- Babcock G,
- Fagin JA.
- 144.↵
- 145.↵
- 146.↵
- Toji S,
- Yabuta N,
- Hosomi T,
- Nishihara S,
- Kobayashi T,
- Suzuki S, et al.
- 147.↵
- Musacchio A,
- Hardwick KG.
- 148.↵
- Crane R,
- Gadea B,
- Littlepage L,
- Wu H,
- Ruderman JV.
- 149.↵
- Vagnarelli P,
- Earnshaw WC.
- 150.↵
- Vader G,
- Medema RH,
- Lens SMA.
- 151.↵
- Adams RR,
- Carmena M,
- Earnshaw WC.
- 152.↵
- Murnion ME,
- Adams RR,
- Callister DM,
- Allis CD,
- Earnshaw WC,
- Swedlow JR.
- 153.↵
- Hsu JY,
- Sun ZW,
- Li XM,
- Reuben M,
- Tatchell K,
- Bishop DK, et al.
- 154.↵
- Lan WJ,
- Zhang X,
- Kline-Smith SL,
- Rosasco SE,
- Barrett-Wilt GA,
- Shabanowitz J, et al.
- 155.↵
- Minoshima Y,
- Kawashima T,
- Hirose K,
- Tonozuka Y,
- Kawajiri A,
- Bao YC, et al.
- 156.↵
- Yang KT,
- Li SK,
- Chang CC,
- Tang CJC,
- Lin YN,
- Lee SC, et al.
- 157.↵
- Avo Santos M,
- van de Werken C,
- de Vries M,
- Jahr H,
- Vromans MJM,
- Laven JSE, et al.
- 158.↵
- 159.↵
- Cirak Y,
- Furuncuoglu Y,
- Yapicier O,
- Aksu A,
- Cubukcu E.
- 160.↵
- 161.↵
- Do TV,
- Xiao F,
- Bickel LE,
- Klein-Szanto AJ,
- Pathak HB,
- Hua X, et al.
- 162.↵
- Davidson B,
- Nymoen DA,
- Elgaaen BV,
- Staff AC,
- Tropé CG,
- Kærn J, et al.
- 163.↵
- Honma K,
- Nakanishi R,
- Nakanoko T,
- Ando K,
- Saeki H,
- Oki E, et al.
- 164.↵
- 165.↵
- Hosseini S,
- Hashemzadeh S,
- Estiar MA,
- Ebrahimzadeh R,
- Fakhree MBA,
- Yousefi B, et al.
- 166.↵
- Liu JM,
- Long XH,
- Zhang GM,
- Zhou Y,
- Chen XY,
- Huang SH, et al.
- 167.↵
- 168.↵
- Takeshita M,
- Koga T,
- Takayama K,
- Ijichi K,
- Yano T,
- Maehara Y, et al.
- 169.↵
- Fujii S,
- Srivastava V,
- Hegde A,
- Kondo Y,
- Shen LL,
- Hoshino K, et al.
- 170.↵
- 171.↵
- 172.↵
- 173.↵
- Tatsuka M,
- Sato S,
- Kitajima S,
- Suto S,
- Kawai H,
- Miyauchi M, et al.
- 174.↵
- 175.↵
- 176.↵
- Hartsink-Segers SA,
- Zwaan CM,
- Exalto C,
- Luijendijk MWJ,
- Calvert VS,
- Petricoin EF, et al.
- 177.↵
- Premkumar DR,
- Jane EP,
- Pollack IF.
- 178.↵
- 179.↵
- Klein A,
- Reichardt W,
- Jung V,
- Zang KD,
- Meese E,
- Urbschat S.
- 180.
- 181.
- Madhavan S,
- Zenklusen JC,
- Kotliarov Y,
- Sahni H,
- Fine HA,
- Buetow K.
- 182.↵
- 183.↵
- Samaras V,
- Stamatelli A,
- Samaras E,
- Arnaoutoglou C,
- Arnaoutoglou M,
- Stergiou I, et al.
- 184.
- Zeng WF,
- Navaratne K,
- Prayson RA,
- Weil RJ.
- 185.↵
- 186.↵
- Rong R,
- Jiang LY,
- Sheikh MS,
- Huang Y.
- 187.↵
- 188.↵
- Noh EM,
- Lee YR,
- Hong OY,
- Jung SH,
- Youn HJ,
- Kim JS.
- 189.↵
- Xia ZB,
- Wei P,
- Zhang H,
- Ding ZM,
- Yang LX,
- Huang ZS, et al.
- 190.↵
- González-Loyola A,
- Fernández-Miranda G,
- Trakala M,
- Partida D,
- Samejima K,
- Ogawa H, et al.
- 191.↵
- 192.↵
- 193.↵
- Ditchfield C,
- Johnson VL,
- Tighe A,
- Ellston R,
- Haworth C,
- Johnson T, et al.
- 194.↵
- Gadea BB,
- Ruderman JV.
- 195.↵
- 196.↵
- Manfredi MG,
- Ecsedy JA,
- Meetze KA,
- Balani SK,
- Burenkova O,
- Chen W, et al.
- 197.↵
- Hoar K,
- Chakravarty A,
- Rabino C,
- Wysong D,
- Bowman D,
- Roy N, et al.
- 198.↵Clinical Study Medical Monitor, Millennium Pharmaceuticals, Inc. A study of MLN8054 in patients with advanced solid tumors. [Accessed June 20, 2018], Available from: https://www.clinicaltrials.gov/ct2/show/NCT00249301?cond=NCT00249301&rank=1.
- 199.↵Millennium Pharmaceuticals, Inc. A phase 1 trial of extended MLN8054 dosing in patients with advanced malignancies. [Accessed June 20, 2018], Available from: https://www.clinicaltrials.gov/ct2/show/NCT00652158?cond=NCT00652158&rank=1.
- 200.↵
- Dees EC,
- Cohen RB,
- von Mehren M,
- Stinchcombe TE,
- Liu H,
- Venkatakrishnan K, et al.
- 201.↵
- Liewer S,
- Huddleston A.
- 202.↵
- van Brocklyn Jr.,
- Wojton J,
- Meisen WH,
- Kellough DA,
- Ecsedy JA,
- Kaur B, et al.
- 203.↵
- Harrington EA,
- Bebbington D,
- Moore J,
- Rasmussen RK,
- Ajose-Adeogun AO,
- Nakayama T, et al.
- 204.↵
- Traynor AM,
- Hewitt M,
- Liu G,
- Flaherty KT,
- Clark J,
- Freedman SJ, et al.
- 205.↵
- Giles FJ,
- Swords RT,
- Nagler A,
- Hochhaus A,
- Ottmann OG,
- Rizzieri DA, et al.
- 206.↵
- Wilkinson RW,
- Odedra R,
- Heaton SP,
- Wedge SR,
- Keen NJ,
- Crafter C, et al.
- 207.↵
- 208.↵
- Li HF,
- Wang HB,
- Sun ZQ,
- Guo Q,
- Shi HY,
- Jia YC.
- 209.↵
- 210.↵
- 211.↵
- Li SS,
- Zhang YJ,
- Xu WF.
- 212.↵
- 213.↵
- Schöffski P,
- Blay JY,
- de Greve J,
- Brain E,
- Machiels JP,
- Soria JC, et al.
- 214.↵
- van den Bossche J,
- Lardon F,
- Deschoolmeester V,
- de Pauw I,
- Vermorken JB,
- Specenier P, et al.
- 215.↵
- Weiss GJ,
- Jameson G,
- von Hoff DD,
- Valsasina B,
- Davite C,
- di Giulio C, et al.
- 216.↵
- Uitdehaag JCM,
- Verkaar F,
- Alwan H,
- de Man J,
- Buijsman RC,
- Zaman GJR.
- 217.↵
- Xu L,
- Zhu YR,
- Shao JJ,
- Chen M,
- Yan H,
- Li GQ, et al.
- 218.↵
- 219.↵
- Zhang Z,
- Zhang GJ,
- Kong CZ.
- 220.↵
- Wang NN,
- Li ZH,
- Zhao H,
- Tao YF,
- Xu LX,
- Lu J, et al.
- 221.↵
- Lee C,
- Fotovati A,
- Triscott J,
- Chen J,
- Venugopal C,
- Singhal A, et al.
- 222.↵
- Lerner RG,
- Grossauer S,
- Kadkhodaei B,
- Meyers I,
- Sidorov M,
- Koeck K, et al.
- 223.↵
- 224.↵
- Li R,
- Murray AW.
- 225.↵
- Rieder CL,
- Schultz A,
- Cole R,
- Sluder G.
- 226.↵
- Bolanos-Garcia VM,
- Blundell TL.
- 227.↵
- Skoufias DA,
- Andreassen PR,
- Lacroix FB,
- Wilson L,
- Margolis RL.
- 228.↵
- Kokkinakis DM,
- Liu XY,
- Chada S,
- Ahmed MM,
- Shareef MM,
- Singha UK, et al.
- 229.↵
- Restall IJ,
- Parolin DAE,
- Daneshmand M,
- Hanson JEL,
- Simard MA,
- Fitzpatrick ME, et al.
- 230.↵
- Maachani UB,
- Tandle A,
- Shankavaram U,
- Kramp T,
- Camphausen K.
- 231.↵
- 232.↵
- 233.↵
- 234.↵
- 235.↵
- Brazeau JF,
- Rosse G.
- 236.↵
- 237.↵
- Altieri DC.
- 238.
- 239.↵
- 240.↵
- 241.↵
- de Necochea-Campion R,
- Chen CS,
- Mirshahidi S,
- Howard FD,
- Wall NR.
- 242.↵
- Mahotka C,
- Wenzel M,
- Springer E,
- Gabbert HE,
- Gerharz CD.
- 243.↵
- Altieri DC.
- 244.↵
- 245.↵
- Jiang GF,
- Ren B,
- Xu L,
- Song SZ,
- Zhu CC,
- Ye FL.
- 246.↵
- 247.↵
- 248.
- Zhang MC,
- Hu CP,
- Chen Q.
- 249.
- 250.
- 251.
- 252.
- 253.↵
- 254.↵
- Chakravarti A,
- Noll E,
- Black PM,
- Finkelstein DF,
- Finkelstein DM,
- Dyson NJ, et al.
- 255.↵
- Chakravarti A,
- Zhai GG,
- Zhang M,
- Malhotra R,
- Latham DE,
- Delaney MA, et al.
- 256.↵
- 257.↵
- Nakahara T,
- Takeuchi M,
- Kinoyama I,
- Minematsu T,
- Shirasuna K,
- Matsuhisa A, et al.
- 258.↵
- 259.↵
- Guo H,
- Wang YX,
- Song T,
- Xin T,
- Zheng ZM,
- Zhong P, et al.
- 260.↵
- Tolcher AW,
- Mita A,
- Lewis LD,
- Garrett CR,
- Till E,
- Daud AI, et al.
- 261.↵
- Giaccone G,
- Zatloukal P,
- Roubec J,
- Floor K,
- Musil J,
- Kuta M, et al.
- 262.↵
- 263.↵
- Castro-Gamero AM,
- Borges KS,
- Moreno DA,
- Suazo VK,
- Fujinami MM,
- de Paula Gomes Queiroz R,
- de Oliveira HF, et al.
- 264.↵
- Tibes R,
- McDonagh KT,
- Lekakis L,
- Bogenberger JM,
- Kim S,
- Frazer N, et al.
- 265.↵
- 266.↵
- Peery RC,
- Liu JY,
- Zhang JT.
- 267.↵
- Lanvin O,
- Monferran S,
- Delmas C,
- Couderc B,
- Toulas C,
- Cohen-Jonathan-Moyal E.
In this issue
G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future
Angel Mauricio Castro-Gamero, Julia Alejandra Pezuk, María Sol Brassesco, Luiz Gonzaga Tone
Cancer Biology & Medicine Nov 2018, 15 (4) 354-374; DOI: 10.20892/j.issn.2095-3941.2018.0030
Jump to section
Related Articles
- No related articles found.
Cited By...
- Proteogenomic Characterization of Primary Oral Squamous Cell Carcinomas Unveils the Extracellular Matrix Remodeling and Immunosuppressive Microenvironment Linked with Lymph Node Metastasis
- HeberFERON distinctively targets Cell Cycle in the glioblastoma-derived cell line U-87MG
- Anti-tumor pharmacology of natural products targeting mitosis
- Thiabendazole Inhibits Glioblastoma Cell Proliferation and Invasion Targeting Mini-chromosome Maintenance Protein 2
- Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis